Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease

Amanda Fitzpatrick, Thurkaa Shanmugalingam, Syed Haider, Rugare Maruzani, Marjan Iravani, Laia Garrigós, José Ángel. García-Sáenz, Patricia Cortez, Fabricio Racca, Salvador Blanch, Manuel Ruiz-Borrego, Griselda Martrat, Mario Mancino, Ana Amaya-Garrido, José Antonio. Guerrero, José Manuel. Pérez-García, Marta Vaz Batista, Sofia Braga, Antonio Llombart-Cussac, Javier Cortés

Open source

DOI
10.1158/1078-0432.ccr-26-1885
Published
2026-10-13
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-1885,
  title = {Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease},
  author = {Amanda Fitzpatrick and Thurkaa Shanmugalingam and Syed Haider and Rugare Maruzani and Marjan Iravani and Laia Garrigós and José Ángel. García-Sáenz and Patricia Cortez and Fabricio Racca and Salvador Blanch and Manuel Ruiz-Borrego and Griselda Martrat and Mario Mancino and Ana Amaya-Garrido and José Antonio. Guerrero and José Manuel. Pérez-García and Marta Vaz Batista and Sofia Braga and Antonio Llombart-Cussac and Javier Cortés},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-1885},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-1885}
}

RIS

TY  - JOUR
TI  - Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease
AU  - Amanda Fitzpatrick
AU  - Thurkaa Shanmugalingam
AU  - Syed Haider
AU  - Rugare Maruzani
AU  - Marjan Iravani
AU  - Laia Garrigós
AU  - José Ángel. García-Sáenz
AU  - Patricia Cortez
AU  - Fabricio Racca
AU  - Salvador Blanch
AU  - Manuel Ruiz-Borrego
AU  - Griselda Martrat
AU  - Mario Mancino
AU  - Ana Amaya-Garrido
AU  - José Antonio. Guerrero
AU  - José Manuel. Pérez-García
AU  - Marta Vaz Batista
AU  - Sofia Braga
AU  - Antonio Llombart-Cussac
AU  - Javier Cortés
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-26-1885
UR  - https://doi.org/10.1158/1078-0432.ccr-26-1885
ER  - 

APA

Fitzpatrick, A., Shanmugalingam, T., Haider, S., Maruzani, R., Iravani, M., Garrigós, L., García-Sáenz, J. Á., Cortez, P., Racca, F., Blanch, S., Ruiz-Borrego, M., Martrat, G., Mancino, M., Amaya-Garrido, A., Guerrero, J. A., Pérez-García, J. M., Batista, M. V., Braga, S., Llombart-Cussac, A., & Cortés, J. (2026). Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-1885

Source records